| Home Market Dynamics Macro Trends Sector Trends Company Insights AI Investing Strategies Sign Up Login |
Sector: Pharmaceuticals
| Bristol-Myers Squibb is experiencing significant advancements in product and service development, driven by the innovative approval of treatments like Opdivo® and a robust focus on immunotherapy and cardiovascular products. The company's growth drug portfolio, which contributes substantially to its revenue, underscores its effective expansion strategies. Recent trends within the healthcare sector further support its position as a leader in innovation and financial reporting. However, challenges in maintaining this momentum may arise from competitive pressures in the pharmaceutical industry and regulatory hurdles. |
| The price action of Bristol-Myers Squibb (BMY) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The trend sentiment at -1.8 is very bearish. The market sentiment at 1.3 is very bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next. There is no clear direction for BMY since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 1.9, and the negative at -0.6 on 2026-03-23. The forces of Sector Price Trend (-2), Stock Price Trend (-1.8), and Market Risk Appetite (-1) will drive down the price. The forces of Price Level Sentiment (1), Option Sentiment (1.5), Sentiment towards Fundamentals (3.1), and Valuation Sentiment (5.9) will drive up the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
Sign up to reveice notifications on Market Movers
| BMY | ||||||||||||||
| Date | Attention | Price | StdDev | Price Level | Change | 10 Day Trend | Trend Sentiment | Hourly Trend Sentiment | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-23 | 0%(0%) | 57 | 2.65% | -3 | -0.84% | -0.51% | -1.8 | -0.3 | 1% | 1.3 | Short | 70% | 3.1 | 6 |
| 2026-03-22 | 0%(0%) | -1.2 | -0.3 | 0.7 | 1.9 | -1 | ||||||||
| 2026-03-21 | 0%(0%) | -1.2 | -0.3 | 0.8 | 1.9 | -1 | ||||||||
| 2026-03-20 | 0%(0%) | 57.48 | 2.31% | -5 | -1.1% | -0.5% | -1.2 | -0.2 | 1.5% | 1 | Wait | 50% | 1.9 | -1 |
| 2026-03-19 | 0%(0%) | 58.12 | 1.98% | -2 | -2.11% | -0.5% | -1.1 | -0.9 | 1.3% | 1.2 | Wait | 50% | 1.7 | -1 |
| 2026-03-18 | 0%(0%) | 59.37 | 1.72% | 17 | -0.57% | -0.33% | -0.5 | -0.3 | 0.9% | 1.4 | Short | 55% | 2 | -1 |
| 2026-03-17 | 0%(0%) | 59.71 | 1.67% | 25 | 0% | -0.33% | -0.5 | -0.2 | 1% | 1.2 | Short | 55% | 1.5 | -1 |
| 2026-03-16 | 0%(0%) | 59.71 | 1.64% | 25 | 1.08% | -0.5% | -0.9 | 0.3 | 0.5% | 0.8 | Wait | 50% | 2 | -1 |
| 2026-03-15 | 0%(0%) | -1 | 0.3 | 1.1 | 3 | -1 | ||||||||
| 2026-03-14 | 0%(0%) | -1 | 0.3 | 0.9 | 3.3 | -1 | ||||||||
| Short is the preferred trading strategy with 70% chance of being right. Both trend sentiment and hourly trend are very weak. Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | ||||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | ||||||||||||||
| Analysis | ||
| ● Bristol Myers Squibb (BMY) – Equity Research Report Fri. Mar 13, 2026 | ||
| 2026-03-23 17:48:23 Bristol Myers Squibb's long history of being a top dividend growth stock suggests financial stability and consistent earnings growth. |
| 2026-03-23 17:48:23 The consistent dividend yield of 4.4% is highlighted as a key factor for investors considering the stock's value. |
| 2026-03-23 17:48:23 The article discusses the stock's potential for generating income through dividends, indicating a positive outlook on investment. |
| 2026-03-23 17:16:37 Bristol-Myers Squibb's leading position in immunotherapy and new data presentation showcases its competitive strength in the industry. |
| 2026-03-23 17:16:37 The company has reported strong net sales growth, indicating a resilient and profitable business despite market challenges. |
| 2026-03-23 17:16:37 Bristol-Myers Squibb is actively developing and expanding its product offerings, particularly in immunotherapy and cardiovascular treatments. |
| 2026-03-23 17:16:37 Recent FDA and EU approvals for Opdivo highlight Bristol-Myers Squibb's success in navigating regulatory landscapes. |
| 2026-03-23 17:16:37 Bristol-Myers Squibb's stock has experienced fluctuations, indicating uncertainty in market performance. |